May 23, 2017
Recommended Topic Related To:


"Robert Lowes
Medscape Medical News

Infection-prone duodenoscopes will remain on the market despite a rash of related multidrug-resistant infections because their benefits still outweigh the low risk for transmitted infecti"...





There have been post-marketing reports of infants who received more than one dose or a replacement dose of RotaTeq after regurgitation [see DOSAGE AND ADMINISTRATION]. In limited post-marketing experience of reported overdosage, the adverse events reported after incorrect administration of higher than recommended doses of RotaTeq were similar to adverse events observed with the approved dosage and schedule.



A demonstrated history of hypersensitivity to any component of the vaccine.

Infants who develop symptoms suggestive of hypersensitivity after receiving a dose of RotaTeq should not receive further doses of RotaTeq.

Severe Combined Immunodeficiency Disease

Infants with Severe Combined Immunodeficiency Disease (SCID) should not receive RotaTeq. Post-marketing reports of gastroenteritis, including severe diarrhea and prolonged shedding of vaccine virus, have been reported in infants who were administered RotaTeq and later identified as having SCID [see ADVERSE REACTIONS].

History Of Intussusception

Infants with a history of intussusception should not receive RotaTeq.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 2/8/2017


RotaTeq - User Reviews

RotaTeq User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication RotaTeq sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

GI Disorders

Get the latest treatment options.